Outlook Therapeutics Appoints Laura Cantrell as VP of Corporate Strategy and Business Development

Outlook Therapeutics has appointed Laura Cantrell as Vice President of Corporate Strategy and Business Development. Cantrell brings over 20 years of experience in global corporate strategy, business development, and portfolio leadership. She will lead the company's business development strategy, including strategic partnerships, licensing opportunities, and corporate development initiatives. Her role will focus on advancing the company's programs, exploring strategic opportunities, and supporting Outlook's next phase of growth.